Shannon W. Finks, Pharm.D., FCCP, BCPS, BCCP, AHSCP-CHC

Department of Clinical Pharmacy and Translational Science

MEMPHIS TN 381632198
Tel: (901) 448-3701


  • Pharm.D., University of Tennessee College of Pharmacy, Pharmacy

Download My Latest Curriculum Vitae

Clinical Care Specialty/Interest

Clinical Pharmacy Specialist in Cardiology

Veterans Affairs Medical Center, Memphis, Tennessee

American Heart Association Instructor Status

Advanced Cardiac Life Support Instructor

     Certified by the American Heart Association,  2001 to present

Advanced Cardiac Life Support Provider

     Certified by the American Heart Association,  1999 to present

American Heart Association Healthcare Instructor

     Certified by the American Heart Association,  2007 to present

American Heart Association Healthcare Provider

     Certified by the American Heart Association,  1997 to present

Honors and Awards

SGAEC Excellence in Teaching Award, UTHSC College of Pharmacy, 2018

Cardiology PRN Mentorship Award, American College of Clinical Pharmacy, 2017

University of Tennessee Alumni Association Outstanding Teacher Award, 2012

Most Influential Professor Award, given by the University of Tennessee College of Pharmacy Class of 2012, 2010

National Faculty for the American College of Clinical Pharmacy (ACCP) Pharmacotherapy and Cardiology Prep Courses, Last Chance Webinars, and Updates to the Updates series in Cardiology 

Board Certifications

Board Certified Cardiology Pharmacist (BCCP) 

Certified by the Board of Pharmaceutical Specialties in 2018

Board Certified Pharmacotherapy Specialist (BCPS)

Certified by the Board of Pharmaceutical Specialties in 2000

Recertification in 2007 and 2014

Added Qualifications in Cardiology (AQ Cardiology) 

Granted by the Board of Pharmaceutical Specialties in 2006

Credentials renewed and granted in 2013 (replaced by BCCP in 2018)

Research Interest/Specialty

Cardiovascular pharmacology, antiplatelets, anticoagulants, hypertension, primary prevention, acute coronary syndrome, heart failure, integrated examination 


  1. Phelps, SJ, McDonough, SK, Parker, RB, Finks, SW. Throwing a curveball: the impact of instructor decisions regarding poorly performing test questions. Am J Pharm Educ, 77 (9), 204, 2013.
  2. Norman, JL, Holmes, WL, Bell, WA, Finks, SW. Life-threatening ACE inhibitor-induced angioedema after eleven years on lisinopril. J Pharm Pract, 26 (4), 382-8, 2013.
  3. Dobesh, PP, Trujillo, TC, Finks, SW. Role of the pharmacist in achieving performance measures to improve the prevention and treatment of venous thromboembolism. Pharmacotherapy, 33 (6), 650-64, 2013.
  4. Rogers, KC, Wallace, JP, Foster, SL, Finks, SW. Annual influenza vaccination: offering protection beyond infection. South Med J, 105 (7), 379-86, 2012.
  5. Rogers, KC, Faircloth, JM, Finks, SW. Use of cilostazol in percutaneous coronary interventions. Ann Pharmacother, 46 (6), 839-50, 2012.
  6. Finks, SW, Airee, A, Chow, SL, Macaulay, TE, Moranville, MP, Rogers, KC, Trujillo, TC. Key articles of dietary interventions that influence cardiovascular mortality. Pharmacotherapy, 32 (4), e54-87, 2012.
  7. Finks, SW, Rogers, KC, Manguso, AH. Assessment of sotalol prescribing in a community hospital: opportunities for clinical pharmacist involvement. Int J Pharm Pract, 19 (4), 281-6, 2011.
  8. Goddard, KB, Eppert, HD, Underwood, EL, McLean, KM, Finks, SW, Rogers, KC. Basic life support and cardiopulmonary resuscitation training for pharmacy students and the community by a pharmacy student committee. Am J Pharm Educ, 74 (6), 100, 2010.
  9. Finks, SW, Oliphant, CS, Manguso, AH, Rogers, KC, Bridges, G, Haidar, CE, Lee, KR, Lee, M, Lobo, B, May, AM, Reaves, A, Swanson, JM, Swims, M, Vinson, J, Yates, ME. Activities of Memphis-area hospitals to meet National Patient Safety Goals for warfarin therapy. Am J Health Syst Pharm, 66 (24), 2179-88, 2009.
  10. Rogers, KC, Finks, SW. Job sharing for women pharmacists in academia. Am J Pharm Educ, 73 (7), 135, 2009.
  11. Czosnowski, QA, Finks, SW, Rogers, KC. Bivalirudin for patients with heparin-induced thrombocytopenia undergoing cardiovascular surgery. Ann Pharmacother, 42 (9), 1304-9, 2008.
  12. Airee, A, Draper, HM, Finks, SW. Aspirin resistance: disparities and clinical implications. Pharmacotherapy, 28 (8), 999-1018, 2008.
  13. Finks, SW. Re-examining the cardiovascular therapeutic benefits of aspirin. South Med J, 101 (7), 679-80, 2008.
  14. Finks, SW, Rogers, KC. Job-sharing. Drs. Finks and Rogers interviewed by Kate Traynor, M.S., AJHP News writer. Am J Health Syst Pharm, 65 (1), 69-72, 2008.
  15. Finks, SW. Bivalirudin use in carotid endarterectomy in a patient with heparin-induced thrombocytopenia. Ann Pharmacother, 40 (2), 340-3, 2006.
  16. Finks, SW, Finks, AL, Self, TH. Hydralazine-induced lupus: maintaining vigilance with increased use in patients with heart failure. South Med J, 99 (1), 18-22, 2006.
  17. Willhite SL, Goebel SR, Scoggin JA. Raloxifene provides an alternative for osteoporosis prevention.. Ann of Pharmacother (32), 834-7, 1998.